Cargando…
Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma
The aim of this study was to explore the roles of GPX2, a member of the glutathione peroxidase family (GPXs, GSH-Px), in cisplatin (DDP) resistance in lung adenocarcinoma (LUAD). GPX2 was found to be the most significantly upregulated gene in a DDP-resistant A549/DDP cell line compared with the pare...
Autores principales: | Du, He, Chen, Bi, Jiao, Nan-Lin, Liu, Yan-Hua, Sun, San-Yuan, Zhang, You-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079220/ https://www.ncbi.nlm.nih.gov/pubmed/32215178 http://dx.doi.org/10.1155/2020/7370157 |
Ejemplares similares
-
Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinoma
por: Zhang, Youwei, et al.
Publicado: (2020) -
Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS-mutated lung cancer cells
por: Wang, Mei, et al.
Publicado: (2022) -
Glutathione peroxidases as oncotargets
por: Jiao, Yang, et al.
Publicado: (2017) -
Glutathione Peroxidase 1 Promotes NSCLC Resistance to Cisplatin via ROS-Induced Activation of PI3K/AKT Pathway
por: Chen, Baishen, et al.
Publicado: (2019) -
Glutathione peroxidase 4 expression predicts poor overall survival in patients with resected lung adenocarcinoma
por: Liu, Chao-Yu, et al.
Publicado: (2022)